Pangea Bio-preview

Pangeabio

Pangea Bio

Private

LondonHealthcare & Life Scienceshttps://www.pangeabio.com/

Last Round

Grant

Oct 20, 2025

Total Funding Raised

$16.6M

Momentum Score

25 /100

Company Overview

Pangea Bio is a biotechnology company developing transformative medicines to treat neurological and neuropsychiatric conditions by using AI to unlock nature's neuroactive chemistry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryAI biotechnatural product drug discoveryneurotherapeuticsCNS disordersdrug discovery platformethnobotanical drug discoveryclinical-stage biotechgenerative AIplant-based therapeuticsmental health therapeuticscomputational metabolomicsdrug candidate out-licensingTrkB activators

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pangea Bio Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pangea Bio Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 20, 2025
Grant	Aug 22, 2024
Accelerator	Mar 5, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Julia Wilde

Co-Founder, Chief People And Impact Officer

Founding Team

Manon Veraart

Co-Founder & Chief Business Officer

Founding Team

Lars Christian Wilde

CEO, Chairman & Co-Founder

Founding Team

Pangea Bio Investors

Notable investors and investment history

Investor	Rounds
Playfair Capital	Series A
F4 Fund	Series A
Metaplanet Holdings	Series A
One Mind	Series A, Accelerator
Innovate UK	Grant
The Michael J. Fox Foundation for Parkinson's Research	Grant, Series A
No Label Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 7, 2026
Monthly visitors increased 59% MoM, reaching 2.4K.
Oct 20, 2025
$1M grant from The Michael J. Fox Foundation

View all signals

Pangea Bio Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pangea Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pangea Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range31

Year Founded2021

Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.